| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.47 | 0.09 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.09 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |